慢性胰腺炎相关良性胆管狭窄临时置入全覆膜自膨式金属支架的长期结局
这项开放标签多国前瞻性研究纳入118例慢性胰腺炎相关良性胆管狭窄患者,临时置入单根全覆膜自膨式金属支架并计划10-12个月取出,随访5年。支架置入后中位58个月时仍免于支架的概率为61.6%,初始狭窄缓解者5年免支架概率为77.4%;严重支架相关不良事件发生率为22.9%,均可通过药物或内镜处理。
要点
- 单根FCSEMS临时置入10-12个月后,5年免支架概率超60%,安全性可接受
- 初始狭窄缓解者5年免支架概率达77.4%,优于总体人群
- 严重CP和较长狭窄长度是狭窄复发的独立预测因素
核心结论
- 慢性胰腺炎相关症状性良性胆管狭窄患者临时置入单根全覆膜自膨式金属支架(FCSEMS)10-12个月后,5年时超过60%仍无症状且免于支架,安全性可接受。
- 临时置入单根FCSEMS可考虑作为慢性胰腺炎合并良性胆管狭窄患者的一线治疗。
研究设计与样本
- 开放标签、多国、前瞻性研究,纳入慢性胰腺炎合并良性胆管狭窄并接受FCSEMS置入、计划10-12个月取出的患者。
- 118例患者符合FCSEMS取出条件,支架置入后随访5年,采用Kaplan-Meier分析评估狭窄缓解及免于再次支架置入的累积概率。
主要发现
- 支架置入后中位58个月(四分位距44-64)时,仍免于支架的概率为61.6%(95%CI 52.5%-70.7%)。
- 在FCSEMS留置结束时狭窄已缓解的94例患者中,5年后仍免于支架的概率为77.4%(95%CI 68.4%-86.4%)。
- 118例中27例(22.9%)发生严重支架相关不良事件,均经药物治疗或再次内镜处理解决。
临床怎么用
- 对慢性胰腺炎相关症状性良性胆管狭窄,可考虑临时置入单根FCSEMS并计划10-12个月取出作为一线治疗。
- 初始狭窄缓解者长期免支架概率较高,可作为预后较好的参考人群。
- 严重慢性胰腺炎或较长狭窄长度者复发风险较高,需加强随访。
- 严重支架相关不良事件发生率约22.9%,但均可通过药物或内镜处理,安全性可接受。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Temporary single, fully covered self-expanding metal stent (FCSEMS) placement for benign biliary strictures (BBSs) associated with chronic pancreatitis (CP) may require fewer interventions than endotherapy with multiple plastic stents and may carry less morbidity than biliary diversion surgery. This study aimed to assess long-term outcomes in CP-associated BBSs after FCSEMS placement and removal. METHODS: In this open-label, multinational, prospective study, subjects with CP and a BBS treated with FCSEMS placement with scheduled removal at 10 to 12 months were followed for 5 years after FCSEMS indwell. Kaplan-Meier analyses assessed BBS resolution and cumulative probability of freedom from recurrent stent placement to 5 years after FCSEMS indwell. RESULTS: One hundred eighteen patients were eligible for FCSEMS removal. At a median of 58 months (interquartile range, 44-64) post-FCSEMS indwell, the probability of remaining stent-free was 61.6% (95% confidence interval [CI], 52.5%-70.7%). In 94 patients whose BBSs resolved at the end of FCSEMS indwell, the probability of remaining stent-free 5 years later was 77.4% (95% CI, 68.4%-86.4%). Serious stent-related adverse events occurred in 27 of 118 patients (22.9%); all resolved with medical therapy or repeated endoscopy. Multivariate analysis identified severe CP (hazard ratio, 2.4; 95% CI, 1.0-5.6; P = .046) and longer stricture length (hazard ratio, 1.2; 95% CI, 1.0-1.4; P = .022) as predictors of stricture recurrence. CONCLUSION: In patients with symptomatic BBSs secondary to CP, 5 years after placement of a single FCSEMS intended for 10 to 12 months indwell, more than 60% remained asymptomatic and stent-free with an acceptable safety profile. Temporary placement of a single FCSEMS may be considered as first-line treatment for patients with CP and BBSs. (Clinical trial registration number: NCT01014390.).
引用
- Lakhtakia S, Reddy N, Dolak W, et al. Long-term outcomes after temporary placement of a self-expanding fully covered metal stent for benign biliary strictures secondary to chronic pancreatitis. Gastrointest Endosc. 2019. PMID: 31494135. doi:10.1016/j.gie.2019.08.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。